MedTrace Logo

The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization

NCT06258564 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12000

Last updated 2025-02-13

No results posted yet for this study

Summary

Assessment of the association between human papillomavirus vaccination (HPV) and recurrences of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) in women undergoing conization.

Conditions

  • Cervical Intraepithelial Neoplasia Grade 2/3
  • Recurrence

Interventions

BIOLOGICAL

vaccination against human papillomavirus infection (HPV vaccination)

Women with or without HPV vaccination before or after excision

Sponsors & Collaborators

  • Charles University, Czech Republic

    lead OTHER

Principal Investigators

  • Marek Petráš, assoc.prof. · Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Prague, Czech Republic

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2024-12-31
Completion
2025-01-30

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06258564 on ClinicalTrials.gov